Ozempic (semaglutide) is a glucagon-like peptide-1 receptor (GLP-1) agonist taken as a weekly injection thats approved by the Food and Drug Administration (FDA) to improve blood sugar control in adults with Type 2 diabetes, reduce the risk of stroke and heart attack in adults with Type 2 diabetes and cardiovascular disease, and help with slowing the progression of kidney disease in people with Type 2 diabetes and chronic kidney disease
Thyroid Nodules and GLP-1 Therapy: What Clinical Data Shows The 2023 FDA safety review of semaglutide noted that the incidence of thyroid nodules was low and similar between treatment and placebo groups in major clinical trials
PubMed Seiwerth, S., Rucman, R., Turkovic, B., Sever, M., Klicek, R., Radic, B., Drmic, D., Stupnisek, M., Misic, M., Vuletic, L.B., & Sikiric, P
I and my sister both had a rare (not recorded) reaction to a medication and I asked my physicians office to report it
You may have adjusted your movement patterns, refined your nutrition, and prioritized rest, yet sometimes the results don't align with your efforts